Compendia Bioscience, Inc.

Ann Arbor, MI 48104

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $4.17MM
First Award Date 09/30/07
Most Recent Award Date 08/01/12

Key Personnel

Last Name Name Awards Contact
Rhodes Daniel R Rhodes 8

8 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/01/12 - 07/31/13

DESCRIPTION (provided by applicant): Micro-RNAs (miRNAs) are small non-coding RNAs that control gene expression by regulating messenger (mRNA) translation. miRNAs can act as oncogenes or tumor suppressors, and the differential expression of miRNAs has been correlated with cancer diagnosis, staging, and prognosis, and has been used to nominate th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/01/11 - 07/31/12

DESCRIPTION (provided by applicant): Micro-RNAs (miRNAs) are small non-coding RNAs that control gene expression by regulating messenger (mRNA) translation. miRNAs can act as oncogenes or tumor suppressors, and the differential expression of miRNAs has been correlated with cancer diagnosis, staging, and prognosis, and has been used to nominate th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/01/10 - 07/31/11

DESCRIPTION (provided by applicant): Micro-RNAs (miRNAs) are small non-coding RNAs that control gene expression by regulating messenger (mRNA) translation. miRNAs can act as oncogenes or tumor suppressors, and the differential expression of miRNAs has been correlated with cancer diagnosis, staging, and prognosis, and has been used to nominate th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-011
Budget: 09/30/09 - 01/31/11

DESCRIPTION (provided by applicant): DNA microarray studies, largely sponsored by the NIH and other granting agencies, have generated a wealth of data uncovering the complex gene expression patterns of cancer. Currently however, there is no unifying organizational or bioinformatics resource to integrate the myriad independent observations into ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/01/09 - 01/31/10

DESCRIPTION (provided by applicant): It is now clear that response to targeted therapies in cancer is dictated by the molecular characteristics of an individual patient's tumor. The industry is increasingly looking to genomics-based analyses to link drug response phenotypes to underlying genetic mutations and multiplex molecular signatures. Such...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-011
Budget: 02/01/09 - 01/31/11

DESCRIPTION (provided by applicant): DNA microarray studies, largely sponsored by the NIH and other granting agencies, have generated a wealth of data uncovering the complex gene expression patterns of cancer. Currently however, there is no unifying organizational or bioinformatics resource to integrate the myriad independent observations into ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-11
Budget: 05/28/08 - 01/31/09

DESCRIPTION (provided by applicant): DNA microarray studies, largely sponsored by the NIH and other granting agencies, have generated a wealth of data uncovering the complex gene expression patterns of cancer. Currently however, there is no unifying organizational or bioinformatics resource to integrate the myriad independent observations into ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-11
Budget: 09/30/07 - 01/31/08

DESCRIPTION (provided by applicant): DNA microarray studies, largely sponsored by the NIH and other granting agencies, have generated a wealth of data uncovering the complex gene expression patterns of cancer. Currently however, there is no unifying organizational or bioinformatics resource to integrate the myriad independent observations into ...